retatrutide type 2 diabetes phase 2 trial Effects of on body composition in people with diabetes: a substudy of a 2, double-blind, parallel-group, placebo-controlled, randomised Retatrutide Phase 2: Type 2

In June 2021, another effective treatment, this one for obesity, got Food and Drug Administration approval

It slows digestion, helping you feel full longer, while reducing cravings and regulating blood sugar

User community feedback supplements formal testing

Bleeding risk assessment should be performed before initiating either medication class

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Medically reviewed by Veronica Hackethal | MD, MSc , Harvard University | University of Oxford | Columbia Vagelos College of Physicians and Surgeons on March 26th, 2026